Tsukamoto, K.; Yamashita, A.; Maeki, M.; Tokeshi, M.; Imai, H.; Fukao, A.; Fujiwara, T.; Okudera, K.; Mizuki, N.; Okuda, K.;
et al. Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types. Vaccines 2024, 12, 1239.
https://doi.org/10.3390/vaccines12111239
AMA Style
Tsukamoto K, Yamashita A, Maeki M, Tokeshi M, Imai H, Fukao A, Fujiwara T, Okudera K, Mizuki N, Okuda K,
et al. Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types. Vaccines. 2024; 12(11):1239.
https://doi.org/10.3390/vaccines12111239
Chicago/Turabian Style
Tsukamoto, Kosuke, Akio Yamashita, Masatoshi Maeki, Manabu Tokeshi, Hirotatsu Imai, Akira Fukao, Toshinobu Fujiwara, Koji Okudera, Nobuhisa Mizuki, Kenji Okuda,
and et al. 2024. "Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types" Vaccines 12, no. 11: 1239.
https://doi.org/10.3390/vaccines12111239
APA Style
Tsukamoto, K., Yamashita, A., Maeki, M., Tokeshi, M., Imai, H., Fukao, A., Fujiwara, T., Okudera, K., Mizuki, N., Okuda, K., & Shimada, M.
(2024). Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types. Vaccines, 12(11), 1239.
https://doi.org/10.3390/vaccines12111239
